Cellumed Completes CELLUDERM POWER Manufacturing Process Improvements, Enhances Product Competitiveness

Cellumed, a company specializing in the manufacturing of bio-medical devices, announced on September 15 that following the quality enhancement of its skin-based medical device product "Celluderm HD Implant" last month, it has now completed improvements to the manufacturing process of "Celluderm Power" to further strengthen product quality competitiveness.

Celluderm Power is an acellular allogeneic dermal matrix skin graft, designed for patient convenience with customizable production, and is currently used in major urology clinics in Korea. Through the recent process improvements, Cellumed has further enhanced product competitiveness by advancing verification procedures based on 3D printing technology and optimizing processes such as sanding and slitting.

According to the company, these improvements have reduced micro-level quality variations that could occur in the previous production process, resulting in greater product consistency and reliability. Notably, the advancement of 3D printer-based verification has helped lower the defect rate, the sanding process has increased surface treatment precision, and slitting has improved both breathability and design completeness.

A Cellumed representative stated, "We have comprehensively improved the quality and manufacturing process of our skin products and completed a package renewal, thereby strengthening our technological capabilities and market competitiveness. We will continue to introduce innovative products that meet global standards and grow as a trusted brand in both the medical and consumer markets."

Meanwhile, Cellumed's "Celluderm Fill" is currently in the final stages of stabilizing its production process and is expected to be supplied to medical sites soon, contributing to sales. "Celluderm Fill" is an injectable product made by micronizing acellular allogeneic dermis and mixing it with purified water, and it is in high demand in the fields of plastic surgery and orthopedics. The company is accelerating final preparations to launch products that meet global quality standards.

This content was produced with the assistance of AI translation services.